Chief Development Officer
Biodesix
Boulder, Colorado, United States
Dr. Pestano heads the Development organization at Biodesix, a leading data-driven diagnostic solutions company. He is the NYS CLEP Laboratory Director of the company’s corporate clinical testing laboratory in Boulder, CO. His greater than 20 years of experience in laboratory and assay development for high complexity molecular diagnostics for oncology includes molecular and proteomic approaches in support of Biodesix Nodify and IQ Lung blood-based tests. Most recently his work has focused on the detection and standardization of testing for cell free nucleic acids as a part of a consortia led by the Friends of Cancer Research. As a critical part of product development Dr. Pestano has fostered innovative key collaborations with leading academic and industry partners across the globe. Prior to Biodesix, Dr. Pestano was at Ventana, a member of the Roche Group, where he led project teams in Pharma Services and in Assay Development. Dr. Pestano received his Ph.D. training at The Graduate Center, City University of New York and conducted his post-doctoral training in cancer immunology at the Dana Farber Cancer Institute, Harvard Medical School.
Droplet Digital PCR (ddPCR) in Precision Oncology and MRD: Perspectives from the Trenches
Wednesday, November 20, 2024
9:00 AM – 9:50 AM PST